blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1383482

EP1383482 - METHOD FOR MANUFACTURING A LOW DOSE PHARMACEUTICAL COMPOSITION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.05.2008
Database last updated on 04.11.2024
Most recent event   Tooltip10.10.2008Lapse of the patent in a contracting statepublished on 12.11.2008  [2008/46]
Applicant(s)For all designated states
Pfizer Products Inc.
Eastern Point Road
Groton, CT 06340 / US
[N/P]
Former [2007/29]For all designated states
Pfizer Products Inc.
Eastern Point Road Groton
Connecticut 06340 / US
Former [2004/05]For all designated states
Pfizer Products Inc.
Eastern Point Road
Groton, Connecticut 06340 / US
Inventor(s)01 / GIERER, Daniel S., Pfizer Global Res. and Dev.
Eastern Point Road
Groton, CT 06340 / US
 [2007/29]
Former [2004/05]01 / GIERER, Daniel S., Pfizer Global Res. and Dev.
Eas tern Point Road
Groton, CT 06340 / US
Representative(s)Wood, David John, et al
UK Patent Department, Pfizer Limited, Ramsgate Road, Sandwich
Kent CT13 9NJ / GB
[N/P]
Former [2004/05]Wood, David John, et al
UK Patent Department, Pfizer Limited, Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
Application number, filing date02702671.513.03.2002
[2004/05]
WO2002IB00766
Priority number, dateUS20010287841P01.05.2001         Original published format: US 287841 P
[2004/05]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO02087546
Date:07.11.2002
Language:EN
[2002/45]
Type: A2 Application without search report 
No.:EP1383482
Date:28.01.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 07.11.2002 takes the place of the publication of the European patent application.
[2004/05]
Type: B1 Patent specification 
No.:EP1383482
Date:18.07.2007
Language:EN
[2007/29]
Search report(s)International search report - published on:EP13.02.2003
ClassificationIPC:A61K9/20, A61K31/40
[2004/05]
CPC:
A61K9/2009 (EP,US); A61K9/20 (KR); A61K31/40 (KR);
A61K9/2095 (EP,US); A61P15/00 (EP); A61P19/10 (EP);
A61P35/00 (EP); A61P5/00 (EP); A61P5/30 (EP);
A61P5/32 (EP); A61K9/2013 (EP,US); A61K9/2054 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/05]
Extension statesAL21.10.2003
LT21.10.2003
LV21.10.2003
MK21.10.2003
RO21.10.2003
SI21.10.2003
TitleGerman:HERSTELLUNGSVERFAHREN FÜR NIEDRIG DOSIERTE PHARMAZEUTISCHE ZUSAMMENSETZUNG[2004/05]
English:METHOD FOR MANUFACTURING A LOW DOSE PHARMACEUTICAL COMPOSITION[2004/05]
French:PROCEDE PERMETTANT DE PREPARER UNE COMPOSITION PHARMACEUTIQUE FAIBLEMENT DOSEE, A REPARTITION ET A ACTIVITE UNIFORMES DU MEDICAMENT[2004/05]
Entry into regional phase21.10.2003National basic fee paid 
21.10.2003Designation fee(s) paid 
21.10.2003Examination fee paid 
Examination procedure18.04.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
21.10.2003Examination requested  [2004/05]
14.04.2004Despatch of a communication from the examining division (Time limit: M04)
02.08.2004Reply to a communication from the examining division
11.01.2007Communication of intention to grant the patent
21.05.2007Fee for grant paid
21.05.2007Fee for publishing/printing paid
Opposition(s)21.04.2008No opposition filed within time limit [2008/26]
Fees paidRenewal fee
19.12.2003Renewal fee patent year 03
31.03.2005Renewal fee patent year 04
31.03.2006Renewal fee patent year 05
02.04.2007Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipMC31.03.2008
[2008/46]
Cited inInternational search[X]GB1570993  (FISONS LTD) [X] 12 * example 1 *;
 [X]EP0503521  (AKZO NV [NL]) [X] 1-3,8-12 * page 3, line 27 - line 35 * * page 3, line 51 - page 4, line 11 * * page 5, line 37 - page 6, line 13 * * examples 1,8 * * claim 10 *;
 [X]EP0700680  (BRISTOL MYERS SQUIBB CO [US]) [X] 12 * page 4; example - *;
 [DA]US5552412  (CAMERON KIMBERLY O [US], et al) [DA] 1-14 * column 8, line 23 - line 65 * * column 19, line 38 - column 20, line 19 * * example 1 ** claim - *;
 [DX]WO9716434  (PFIZER [US], et al) [DX] 12-14 * page 1, line 12 - line 13; example 1 * * page 6, line 18 - page 7, line 15 *;
 [X]WO0115724  (MUTUAL PHARMACEUTICAL CO [US], et al) [X] 1-3,8-11 * example 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.